The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries

Health Policy

Volumn 95, Issue 2-3, 2010, Pages 174-184

  Oortwijn, Wija ^a   Mathijssen, Judith ^a   Banta, David ^a  

^a ECORYS Netherlands   (Netherlands)

Author keywords

Health technology assessment; Middle income countries; Pharmaceutical reimbursement

Indexed keywords

ARTICLE; CONTROLLED STUDY; DECISION MAKING; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH TECHNOLOGY ASSESSMENT; HUMAN; INCOME; QUALITY CONTROL; REIMBURSEMENT;

ARGENTINA; BRAZIL; CHINA; COLOMBIA; DECISION MAKING, ORGANIZATIONAL; DEVELOPING COUNTRIES; DRUG AND NARCOTIC CONTROL; GOVERNMENT REGULATION; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; ISRAEL; MARKETING OF HEALTH SERVICES; MEXICO; NATIONAL HEALTH PROGRAMS; PHILIPPINES; REIMBURSEMENT MECHANISMS; REPUBLIC OF KOREA; TAIWAN; TECHNOLOGY ASSESSMENT, BIOMEDICAL; THAILAND; TURKEY;

EID: 77950949728     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2009.12.008     Document Type: Article

References (24)

1. Facey K. In: Topfer LA, Chan L. on behalf of the International Network of Agencies for Health Technology Assessment. Health Technology Assessment (HTA) Glossary. first ed. Stockholm: INAHTA Secretariat; 2006.
2. Sorenson C, Drummond M, Kanavos P. Ensuring value for money in health care. Copenhagen: World Health Organization, on behalf of the European Observatory on Health Systems and Policies; 2008.
3. Børlum Kristensen F, Palmhøj Nielsen C, Chase B, Lampe K, Lee-Robin SH, Makela M. What is health technology assessment? In: Velasco Garrido M, Børlum Kristensen F, Palmhøj Nielsen C, Busse R, editors. Health technology assessment and health policy-making in Europe: current status, challenges and potential. Copenhagen: World Health Organization, on behalf of the European Observatory on Health Systems and Policies; 2008.
4. Catalan Agency for Health Technology Assessment and Research. EUnetHTA Work Package 8. EUnetHTA Handbook on Health Technology Assessment Capacity Building. Barcelona: Catalan Health Service. Department of Health Autonomous Government of Catalonia; 2008.
5. Bravo Vergel Y, Ferguson B, Iglesias C. The use of cluster analysis to identify factors that influence the establishment of Health Technologies Assessment (HTA) agencies. Centre for Health Economics, University of York. Presentation at iHEA, Barcelona, July 10-13; 2005.
6. Cranovsky R., Matillon Y., Banta H.D. EUR-ASSESS project subgroup on coverage. International Journal of Technology Assessment in Health Care 1997, 13:287-332.
7. MSCI Barra. MSCI Emerging Markets. , visited 11.03.09. http://www.mscibarra.com/products/indices/licd/em.html.
8. Kárpáti K., Sándor J. Letter to the editor. Development of health technology assessment in Central Europe. International Journal of Technology Assessment in Health Care 2009, 25:596-597.
9. Yang R, Tian X, Waters H, Shi G. Financial protection in health in rural China, 1978-2005: trends and current status. Future Health Systems Working Paper 3, China Series, March; 2008.
10. Jurberg C. Flawed but fair: Brazil's health system reaches out to the poor. Bulletin of the World Health Organization 2008, 86(4):248-249.
11. World Health Organization (WHO). The World Health Report 2008. Primary health care now more than ever. Geneva; 2008.
12. Link B.G., Phelan J.C. Fundamental sources of health inequalities. Policy changes in modern health care 2005, Rutgers University Press.
13. Tsang S., Sun J., Qu Q., Chen W. Pharmaceutical policy in China: issues and problems 2008.
14. Eggleston K., Sun Q., Santoro M.A., Meng Q., Liu C. Pharmaceutical policy in China. Health Affairs 2008, 27(4):1042-1050.
15. PAHO/WHO. Developing Health Technology Assessment in Latin America and the Caribbean. Health Systems and Services Development Division. Washington, DC; 1998.
16. Hailey D., Menon D. A short history of INAHTA. International Journal of Technology Assessment in Health Care 1999, 15:236-242.
17. Hailey D. Development of the International Network of Agencies for Heath Technology Assessment. International Journal of Technology Assessment in Health Care 2009, 25(Suppl. 1):24-27.
18. Banta H.D. HTA in Latin America and the Caribbean. International Journal of Technology Assessment in Health Care 2009, 25(SUPPL. 1):253-254.
19. Iglesias C.P., Drummond M.F., Rovira J. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. International Journal of Technology Assessment in Health Care 2005, 21:1-14.
20. Sorensen C, Drummond M, Børlum Kristensen F, Busse R. How can the impact of health technology assessment be enhanced? Policy brief. on behalf of the European Observatory on Health Systems and Policies. Copenhagen: World Health Organization; 2008.
21. Banta H.D., Almeida R.T. Health technology assessment in Brazil. International Journal of Technology Assessment in Health Care 2009, 25(SUPPL. 1):255-259.
22. Tarn T.Y.-H. Case of Taiwan HTA. Presentation at the 3rd Asia-Pacific ISPOR Conference, 8 September 2008.
23. Kim C. Health technology assessment in South Korea. International Journal of Technology Assessment in Health Care 2009, 25(SUPPL. 1):219-223.
24. Moga C., Corabian P., Juzwishin D., Enachescu D., Hailey D. Developing health technology assessment in Romania. Eurohealth 2003, 9(3):30-34.